Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Wedlund

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
MLO: Medical Laboratory Observer|September 25, 2001
Practical considerations for pharmacogenetic testingP J Wedlund
Pharmacology|September 6, 2000
The CYP2C19 enzyme polymorphismP J Wedlund
Methods in Enzymology|January 1, 1996
In vivo and in vitro measurement of CYP2C19 activityP J Wedlund, G R Wilkinson
Journal of Chromatography|August 22, 1986
A problem with quantitation of mephenytoin enantiomers due to chiral interference from its N-demethylated metaboliteS H Akrawi, P J Wedlund
Journal of Pharmaceutical Sciences|August 1, 1983
Time-dependent kinetics VII: effect of diurnal oscillations on the time course of carbamazepine autoinduction in the rhesus monkeyP J Wedlund, R H Levy
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1989
Mephenytoin stereoselective elimination in the rat: I. Enantiomeric disposition following intravenous administrationS H Akrawi, P J Wedlund
Journal of Pharmaceutical Sciences|March 1, 1984
Hepatic tissue binding and the oral first-pass effectP J Wedlund, G R Wilkinson
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1990
Mephenytoin stereoselective elimination in the rat: III. Stereoselective time course of induction during chronic hepatic portal vein administrationS H Akrawi, P J Wedlund
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1992
Reversible metabolism of vitamin K-vitamin K epoxide: modeling considerations and limitationsH O Hallak, P J Wedlund
Journal of Clinical Pharmacology|February 1, 1992
Genetic aspects of drug disposition and therapeuticsR J Guttendorf, P J Wedlund
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
MLO: Medical Laboratory Observer|September 25, 2001
Practical considerations for pharmacogenetic testingP J Wedlund
Pharmacology|September 6, 2000
The CYP2C19 enzyme polymorphismP J Wedlund
Methods in Enzymology|January 1, 1996
In vivo and in vitro measurement of CYP2C19 activityP J Wedlund, G R Wilkinson
Journal of Chromatography|August 22, 1986
A problem with quantitation of mephenytoin enantiomers due to chiral interference from its N-demethylated metaboliteS H Akrawi, P J Wedlund
Journal of Pharmaceutical Sciences|August 1, 1983
Time-dependent kinetics VII: effect of diurnal oscillations on the time course of carbamazepine autoinduction in the rhesus monkeyP J Wedlund, R H Levy
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1989
Mephenytoin stereoselective elimination in the rat: I. Enantiomeric disposition following intravenous administrationS H Akrawi, P J Wedlund
Journal of Pharmaceutical Sciences|March 1, 1984
Hepatic tissue binding and the oral first-pass effectP J Wedlund, G R Wilkinson
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1990
Mephenytoin stereoselective elimination in the rat: III. Stereoselective time course of induction during chronic hepatic portal vein administrationS H Akrawi, P J Wedlund
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1992
Reversible metabolism of vitamin K-vitamin K epoxide: modeling considerations and limitationsH O Hallak, P J Wedlund
Journal of Clinical Pharmacology|February 1, 1992
Genetic aspects of drug disposition and therapeuticsR J Guttendorf, P J Wedlund
Pageof 6